Pelargonium Extract EPs 7630 in the Treatment of Human Corona Virus-Associated Acute Respiratory Tract Infections - A Secondary Subgroup-Analysis of an Open-Label, Uncontrolled Clinical Trial

Tilman Keck; Andreas Strobl; Andreas Weinhäusel; Petra Funk; Martin Michaelis

doi:10.3389/fphar.2021.666546

Pelargonium Extract EPs 7630 in the Treatment of Human Corona Virus-Associated Acute Respiratory Tract Infections - A Secondary Subgroup-Analysis of an Open-Label, Uncontrolled Clinical Trial

Tilman Keck
, Andreas Strobl
, Andreas Weinhäusel
, Petra Funk
, Martin Michaelis

Molecular Diagnostics

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-11
Number of pages	11
Journal	Frontiers in Pharmacology
Volume	12
Issue number	12
DOIs	https://doi.org/10.3389/fphar.2021.666546
Publication status	Published - 2021

Research Field

Molecular Diagnostics

Access to Document

10.3389/fphar.2021.666546Licence: Unspecified

Cite this

@article{359128af3a834b62bbf961c4ca8c1e93,

title = "Pelargonium Extract EPs 7630 in the Treatment of Human Corona Virus-Associated Acute Respiratory Tract Infections - A Secondary Subgroup-Analysis of an Open-Label, Uncontrolled Clinical Trial",

author = "Tilman Keck and Andreas Strobl and Andreas Weinh{\"a}usel and Petra Funk and Martin Michaelis",

year = "2021",

doi = "10.3389/fphar.2021.666546",

language = "English",

volume = "12",

pages = "1--11",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

publisher = "Frontiers Media S.A.",

number = "12",

}

Pelargonium Extract EPs 7630 in the Treatment of Human Corona Virus-Associated Acute Respiratory Tract Infections - A Secondary Subgroup-Analysis of an Open-Label, Uncontrolled Clinical Trial. / Keck, Tilman; Strobl, Andreas; Weinhäusel, Andreas et al.
In: Frontiers in Pharmacology, Vol. 12, No. 12, 2021, p. 1-11.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Pelargonium Extract EPs 7630 in the Treatment of Human Corona Virus-Associated Acute Respiratory Tract Infections - A Secondary Subgroup-Analysis of an Open-Label, Uncontrolled Clinical Trial

AU - Keck, Tilman

AU - Strobl, Andreas

AU - Weinhäusel, Andreas

AU - Funk, Petra

AU - Michaelis, Martin

PY - 2021

Y1 - 2021

U2 - 10.3389/fphar.2021.666546

DO - 10.3389/fphar.2021.666546

M3 - Article

SN - 1663-9812

VL - 12

SP - 1

EP - 11

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

IS - 12

ER -